In the Cancer Genome Atlas (TCGA) database, we compared DNASE1L3 expression of colon cancer samples with normal samples at the mRNA level and found that DNASE1L3 expression was significantly lower in the tumor group than in the normal group (Figure 4A). This evidence concerns the gene DNASE1L3 and neoplasm.